Loading...
An in vitro investigation into the protective and genotoxic effects of myricetin bulk and nano forms in lymphocytes of MGUS patients and healthy individuals
Akhtar, Shabana Najafzadeh, Mojgan Isreb, Mohammad Newton, L. Gopalan, Rajendran C. Anderson, Diana
Akhtar, Shabana
Najafzadeh, Mojgan
Isreb, Mohammad
Newton, L.
Gopalan, Rajendran C.
Anderson, Diana
Publication Date
2020-07
End of Embargo
Supervisor
Rights
© 2020 Elsevier B.V. Reproduced in accordance with the publisher's self-archiving policy. This manuscript version is made available under the CC-BY-NC-ND 4.0 license.
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
17/03/2020
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
The present study investigated the genoprotective and genotoxic effects of myricetin bulk (10 μM) and nano forms (20 μM) in the lymphocytes from pre-cancerous, monoclonal gammopathy of unknown significance (MGUS) patients and healthy individuals using the Comet and micronucleus assays. The study also evaluated the effect of myricetin on P53 expression levels, using the Western blot technique. Results showed that throughout the in-vitro treatment, lymphocytes from the patients group had higher levels of baseline DNA damage compared to the healthy group. Myricetin in both forms induced significant DNA damage, only at higher concentrations (>40 μM). The micronucleus assay showed a significant reduction (P < 0.01) in the frequency of micronuclei in mono-nucleated cells in the patient group treated with the nano form of myricetin at the non-toxic dose of 20 μM. There was a significant increase in both gene and protein P53 levels in lymphocytes isolated from healthy individuals and pre-cancerous patients. These results suggested a protective effect of myricetin and indicated its nutritional supplement potential for protection against cancer development among patients suffering from MGUS.
Version
Accepted manuscript
Citation
Akhtar S, Najafzadeh M, Isreb M et al (2020) An in vitro investigation into the protective and genotoxic effects of myricetin bulk and nano forms in lymphocytes of MGUS patients and healthy individuals. Toxicology Letters. 327: 33-40.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article